Loading...
Market
What will be the public approval rating of the free vaccine provision under the Inflation Reduction Act in 2024?
4
Resolution / Starting Odds
Under 30% approval • 25%
30%-60% approval • 25%
60%-90% approval • 25%
Above 90% approval • 25%
Public opinion polls conducted by major health policy organizations
Story
2023 Inflation Reduction Act Provides Free Vaccines to Over 10M Medicare Enrollees
May 5, 2024, 04:00 AM
During World Immunization Week, it was highlighted that the Inflation Reduction Act has significantly impacted public health by providing free vaccines to over 10 million Medicare enrollees in 2023. These vaccines, including shingles, tetanus, Tdap, hepatitis A, and hepatitis B, are now accessible at no cost to individuals with Medicare Part D, marking a substantial increase from the 3 million who benefited in 2021. This legislative measure not only enhances health outcomes but also offers financial relief by reducing the cost burden of vaccinations.
View original story
Similar markets
Below 40% • 25%
40% to 55% • 25%
55% to 70% • 25%
Above 70% • 25%
Below 40% • 25%
40% to 60% • 25%
60% to 80% • 25%
Above 80% • 25%
High support (>70%) • 25%
Moderate support (50-70%) • 25%
Low support (30-50%) • 25%
Very low support (<30%) • 25%
Highly favorable • 25%
Somewhat favorable • 25%
Somewhat unfavorable • 25%
Highly unfavorable • 25%
High approval (over 70%) • 33%
Moderate approval (40% to 70%) • 34%
Low approval (under 40%) • 33%
Majority approval • 33%
Neutral • 34%
Majority disapproval • 33%
Below 30% • 25%
30% to 50% • 25%
50% to 70% • 25%
Above 70% • 25%
High support (>60%) • 25%
Moderate support (40-60%) • 25%
Low support (20-40%) • 25%
Very low support (<20%) • 25%
Support over 75% • 25%
Support 50-75% • 25%
Support 25-50% • 25%
Support under 25% • 25%
Widespread support • 25%
Moderate support • 25%
Divided opinion • 25%
Widespread opposition • 25%
Below 30% • 25%
30% to 50% • 25%
51% to 70% • 25%
Above 70% • 25%